Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.
Rivero-Juarez A, López-Cortés LF, Camacho A, Mira JA, Téllez F, Marquez M, Merino D, Pineda JA, Rivero A; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR), part of the Sociedad Andaluza de Enfermedades Infecciosas. Rivero-Juarez A, et al. Clin Infect Dis. 2014 Jan;58(1):130-3. doi: 10.1093/cid/cit653. Epub 2013 Sep 24. Clin Infect Dis. 2014. PMID: 24065317
Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients.
Rivero-Juarez A, Martinez-Dueñas L, Martinez-Peinado A, Camacho A, Cifuentes C, Gordon A, Frias M, Torre-Cisneros J, Pineda JA, Rivero A. Rivero-Juarez A, et al. J Infect. 2015 Jun;70(6):680-3. doi: 10.1016/j.jinf.2014.11.010. Epub 2014 Nov 29. J Infect. 2015. PMID: 25453620 No abstract available.
Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance.
Rivero-Juarez A, Caruz A, Real LM, Martinez-Dueñas L, Marquez FJ, Frias M, Recio E, Gordon A, Pineda JA, Rivero A, Camacho A; Group for the Study of Viral Hepatitis (HEPAVIR) of the Andalusian Society of Infectious Diseases (SAEI). Rivero-Juarez A, et al. Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2171-5. doi: 10.1007/s10096-015-2463-1. Epub 2015 Aug 9. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26254560
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.
Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda JA, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A, Rivero A. Frías M, et al. Pharmacogenomics J. 2017 Dec;17(6):551-555. doi: 10.1038/tpj.2016.42. Epub 2016 May 31. Pharmacogenomics J. 2017. PMID: 27241060
203 results